STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

SCHEDULE OF COMMON STOCK WARRANTS

The following schedule summarizes the changes in the Company’s common stock warrants:

					Weighted				Weighted
	Warrants Outstanding				Average				Average
	Number		Exercise		Remaining		Aggregate		Exercise
	Of		Price		Contractual		Intrinsic		Price
	Shares		Per Share		Life		Value		Per Share
Balance at December 31, 2022		121,547	$	0.008 - 16.00		1.37 years	$	273	$	8.31
Warrants granted		-	$	-		-	$		$
Warrants exercised		-	$	-		-	$		$
Warrants expired/cancelled		-	$	-		-	$		$
Balance at March 31, 2023		121,547	$	0.008 - 16.00		8.31 years	$	60,706	$	1.12
Exercisable at March 31, 2023		119,721	$	0.008 - 16.00		years	$	58,438	$	1.13
Balance at December 31, 2021		437,691	$	0.008 - 16.00		2.69 years	$	1,185,798	$	5.36
Warrants granted		-	$	-		-			$
Warrants exercised/exchanged		-	$	-		-			$
Warrants expired/cancelled		-	$	-		-			$
Balance at March 31, 2022		437,691	$	0.008 - 16.00		2.49 years	$	1,151,551	$	5.38
Exercisable at March 31, 2022		412,050	$	0.008 - 16.00		2.49 years	$	1,022,268	$	5.71

SCHEDULE OF EACH OPTION WARRANT ESTIMATED USING THE BLACK-SCHOLES VALUATION MODEL

	Three Months Ended March 31, 2023		Year Ended December 31, 2022
Risk free interest rate	2.00 – 25.00	%	-	%
Expected term	0.87 – 3.55 years		-
Expected volatility	169.91% - 268.79	%	-	%
Expected dividend yield	0.00 – 0.00	%	-	%